fbpx

U.S. Anti-Doping Agency (USADA)

Global DRO logo in whiteSearch Medications & Ingredients

Athlete Login >

GlobalDRO >
Medication Search >

Year: 2018

U.S. Paralympic Boccia Athlete Marck Harrison Accepts Public Warning

January 24, 2018 USADA announced today that Marck Harrison, of Columbus, Ohio, an athlete in the sport of Paralympic boccia, has accepted a public warning for failing to obtain a Therapeutic Use Exemption (TUE) prior to his use of an otherwise prohibited medication. Harrison’s violation resulted from his use of a prescription medication containing chlorthalidone

Read More »
racquetball racquet and ball

U.S. Racquetball Athlete Sharon Jackson Accepts Public Warning

January 24, 2018 USADA announced today that Sharon Jackson, of Atlanta, Ga., an athlete in the sport of racquetball, has accepted a public warning for failing to obtain a Therapeutic Use Exemption (TUE) prior to her use of an otherwise prohibited medication. Jackson’s violation resulted from her use of a prescription medication containing spironolactone –

Read More »
weightlifter

U.S. Weightlifting Athlete Lemuel Grayson Accepts Public Warning

January 22, 2018 USADA announced today that Lemuel Grayson, of Colorado Springs, Colo., an athlete in the sport of weightlifting, has accepted a public warning for failing to obtain a Therapeutic Use Exemption (TUE) prior to his use of an otherwise prohibited medication. Grayson’s violation resulted from his use of a prescription medication containing hydrochlorothiazide

Read More »

NADO Leaders Request Clear Criteria and a Transparent Process for Selection of Olympic Athletes from Russia

Leaders from 19 National Anti-Doping Organisations (NADOs) came together for a fifth special summit, this time in Bonn, to discuss the urgent questions that are still unanswered in the lead up to the Olympic Winter Games. NADO leaders are speaking out to support clean athletes who face an uncertain playing field and who have voiced their concern that clean competition has been compromised.

Read More »
Scroll to Top